EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Outcomes of Percutaneous Cryoablation for Localized Renal Cell Carcinoma in Very Elderly Patients

Yohei Okuda iD, Taigo Kato iD, Akira Nagahara, Motohide Uemura, Yusuke Ono, Hiroki Higashihara, Akihiro Yoshimura, Masaru Tani iD, Yuki Horibe, Toshiki Oka, Toshihiro Uemura, Akinaru Yamamoto iD und 7 weitere

International Journal of Urology · 2026-11 · 33 (11)

DOI: 10.1111/iju.70714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 13.11.2026. Verfasst von Yohei Okuda und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The University of Osaka Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Cryosurgery, Carcinoma, Renal Cell, Kidney Neoplasms, Postoperative Complications. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Treatment of localized renal cell carcinoma (RCC) in very elderly patients requires balancing oncological control against treatment‐related morbidity and competing mortality. We evaluated the clinical outcomes and safety of percutaneous cryoablation (PCA), focusing on patients aged ≥ 80 years.

Methods

We retrospectively analyzed 101 patients with localized RCC who underwent computed tomography–guided PCA between April 2014 and March 2022, including 61 aged < 80 years and 40 aged ≥ 80 years. Initial local control was assessed by routine renal biopsy 3 months after PCA. Overall survival (OS), cancer‐specific survival (CSS), conditional recurrence‐free survival (cRFS) after biopsy‐confirmed initial local control, renal function, and complications were evaluated.

Results

Median follow‐up was 52.7 months overall, 63.7 months in patients aged < 80 years, and 37.4 months in those aged ≥ 80 years. Three‐month biopsy was completed in 94 of 101 patients (93.1%), including 58 of 61 (95.1%) aged < 80 years and 36 of 40 (90.0%) aged ≥ 80 years. Among biopsy‐evaluable patients, 91 of 94 (96.8%) had no residual malignancy; in the ≥ 80‐year group, 34 of 36 (94.4%) had no residual malignancy. In patients aged ≥ 80 years, the 5‐year OS, CSS, and cRFS rates were 81.2% (95% CI, 68.4%–94.0%), 100%, and 81.8% (95% CI, 44.7%–95.1%), respectively. Grade ≥ 3 complications occurred in one patient aged ≥ 80 years (2.5%; cerebral infarction) and one aged < 80 years (1.6%; hematoma).

Conclusions

In this selected cohort of patients aged ≥ 80 years, PCA was associated with a high rate of biopsy‐confirmed initial local control and a low incidence of major complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryosurgeryCarcinoma, Renal CellKidney NeoplasmsPostoperative ComplicationsHumansFemaleAged, 80 and overMaleRetrospective StudiesTreatment OutcomeTomography, X-Ray ComputedAgedBiopsyAge FactorsKidneyFollow-Up Studies

Stichwörter der Autor:innen

PCApercutaneous cryoablationsmall renal cell carcinoma

Autor:innen und Institutionen

  • Department of Urology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
  • Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Department of Urology, Iwase General Hospital, Fukushima, Japan.
  • Department of Diagnostic and Interventional Radiology, The University of Osaka Graduate School of Medicine, Osaka, Japan.

ORCID-Profile: Yohei Okuda, Taigo Kato, Masaru Tani, Akinaru Yamamoto, Gaku Yamamichi, Yu Ishizuya, Takuji Hayashi, Yoshiyuki Yamamoto, Koji Hatano, Atsunari Kawashima

Zitieren

APA

Okuda, Y., Kato, T., Nagahara, A., Uemura, M., Ono, Y., Higashihara, H., Yoshimura, A., Tani, M., Horibe, Y., Oka, T., Uemura, T., Yamamoto, A., Yamamichi, G., Ishizuya, Y., Hayashi, T., Yamamoto, Y., Hatano, K., Kawashima, A., & Nonomura, N. (2026). Clinical Outcomes of Percutaneous Cryoablation for Localized Renal Cell Carcinoma in Very Elderly Patients. International Journal of Urology, 33(11). https://doi.org/10.1111/iju.70714

Vancouver

Okuda Y, Kato T, Nagahara A, Uemura M, Ono Y, Higashihara H, et al. Clinical Outcomes of Percutaneous Cryoablation for Localized Renal Cell Carcinoma in Very Elderly Patients. International Journal of Urology. 2026;33(11). doi:10.1111/iju.70714

BibTeX
@article{Okuda2026,
  author = {Okuda, Yohei and Kato, Taigo and Nagahara, Akira and Uemura, Motohide and Ono, Yusuke and Higashihara, Hiroki and Yoshimura, Akihiro and Tani, Masaru and Horibe, Yuki and Oka, Toshiki and Uemura, Toshihiro and Yamamoto, Akinaru and Yamamichi, Gaku and Ishizuya, Yu and Hayashi, Takuji and Yamamoto, Yoshiyuki and Hatano, Koji and Kawashima, Atsunari and Nonomura, Norio},
  title = {Clinical Outcomes of Percutaneous Cryoablation for Localized Renal Cell Carcinoma in Very Elderly Patients},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {11},
  doi = {10.1111/iju.70714}
}
Kostenlos starten →